Omega Diagnostics Group PLC
("Omega" or "the Company")
Announcement of results
Omega (AIM: ODX), the medical diagnostics company, announces that it will release its results for the year ended 31 March 2018 on Monday 6 August 2018.
Further to the disposal of our infectious disease business (excluding VISITECT® CD4), which we announced on 28 June 2018, the extended timeline for releasing results will enable the Company to prioritise its stated objectives.
Contacts:
Omega Diagnostics Group PLC |
Tel: 01259 763 030 |
David Evans, Chairman Colin King, Chief Executive |
|
Kieron Harbinson, Group Finance Director |
|
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) |
|
Camille Gochez (Corporate Broking) |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
Helen Cresswell |
Mob: 07841 917 679 |
Paul McManus |
Mob: 07980 541 893 |